TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $128,291 | -79.9% | 8,530 | -84.2% | 0.01% | -80.4% |
| Q4 2022 | $638,477 | +138.2% | 53,971 | +19.1% | 0.05% | +130.0% |
| Q3 2022 | $268,000 | -33.5% | 45,300 | -52.3% | 0.02% | -45.9% |
| Q2 2022 | $403,000 | +358.0% | 94,990 | +5468.0% | 0.04% | +311.1% |
| Q4 2020 | $88,000 | +238.5% | 1,706 | +70.4% | 0.01% | +200.0% |
| Q3 2020 | $26,000 | +160.0% | 1,001 | +87.5% | 0.00% | +200.0% |
| Q2 2020 | $10,000 | +400.0% | 534 | +151.9% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | -92.9% | 212 | -91.8% | 0.00% | -66.7% |
| Q4 2019 | $28,000 | -48.1% | 2,599 | -32.0% | 0.00% | -40.0% |
| Q1 2018 | $54,000 | -73.0% | 3,822 | -80.8% | 0.01% | -85.7% |
| Q3 2015 | $200,000 | +146.9% | 19,882 | +305.8% | 0.04% | +133.3% |
| Q2 2015 | $81,000 | +350.0% | 4,900 | +308.3% | 0.02% | +275.0% |
| Q1 2015 | $18,000 | -82.5% | 1,200 | -81.7% | 0.00% | -87.9% |
| Q4 2014 | $103,000 | – | 6,548 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
| RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
| KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
| Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
| Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
| Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
| MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
| SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
| 683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |